Luson Bioventures

Luson Bioventures

Biotechnology Research

Mental health focused venture creation

About us

We focus on venture creation of biotechnology and pharmaceutical drug discovery & development companies. Our philosophy is based on the fundamentals of venture creation and due diligence to launch relatively mature and vetted start-up companies. We build value with experienced executives and drug development teams, focused scientific and development milestones, active advisors, and a virtual or quasi-virtual business model for capital efficiency. Portfolio companies: Gate Neurosciences, Anagin, other stealth mental health focused companies in progress; Assembly Pharmaceuticals (now Assembly Biosciences, Nasdaq: ASMB); Assembly China, Naurex (Acquired by Allergan), Aptinyx (Nasdaq: APTX; Naurex spin out); Coferon/Blink Bio, others not disclosed.

Industry
Biotechnology Research
Company size
2-10 employees
Type
Privately Held
Founded
2007

Employees at Luson Bioventures

Similar pages